You are in:Home/Publications/Differential Expression of Autophagy-Related Marker (Beclin-1) in Relation to Clinicopathological Parameters in Different Breast Cancer Molecular Subtypes

Prof. Ranih Zakaria Amer :: Publications:

Title:
Differential Expression of Autophagy-Related Marker (Beclin-1) in Relation to Clinicopathological Parameters in Different Breast Cancer Molecular Subtypes
Authors: RANIH Z. AMER; SHAIMAA M.N. EL-ZAMLY; HALA A. AGINA and MONA A.M. ABO EL-KHAIR
Year: 2019
Keywords: Breast carcinoma – Molecular subtypes – Autophagy, Beclin-1.
Journal: Med. J. Cairo Univ.
Volume: 87
Issue: 2
Pages: 1209-1217
Publisher: Not Available
Local/International: Local
Paper Link: Not Available
Full paper Ranih Zakaria Amer_beclin1 in breast.pdf
Supplementary materials Not Available
Abstract:

Background: Beclin-1 plays a vital role in the vesicle nucleation in the process of autophagy and has an important role in development, tumorigenesis, and neurodegeneration. Aim of Study: Study the role of beclin-1 and correlate the degree of its expression with available clinic-pathological data in different molecular types of breast cancer. Material and Methods: Immunohistochemistry was performed to examine the expression of Beclin-1 different molecular subtypes of invasive ductal carcinoma and correlating it to clinicopathological parameter. Results: The expression of Beclin-1 was decreased in breast cancer in relation to normal tissue. High expression was significantly correlated with tumor grade, distant metastasis and stage. All the cases with high Beclin-1 expression were triple negative breast cancer cases. Conclusions: Triple negative breast cancer cases showed the highest tumor stage, grade, distant metastasis and beclin- 1 expression suggesting that the overexpression of Beclin 1 may by itself confer an aggressive biological course. It could be a therapeutic target.

Google ScholarAcdemia.eduResearch GateLinkedinFacebookTwitterGoogle PlusYoutubeWordpressInstagramMendeleyZoteroEvernoteORCIDScopus